A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease
Public ClinicalTrials.gov record NCT04583735. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 4, Randomized, Double-masked, Placebo-controlled, Multicenter Trial to Evaluate the Efficacy and Safety of TEPEZZA® in Treating Patients With Chronic (Inactive) Thyroid Eye Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The overall objective is to investigate the efficacy, safety and tolerability of TEPEZZA® in participants with chronic (inactive) TED (thyroid eye disease). Approximately 57 participants will be enrolled. There will be a treatment period (through Week 24) and a follow up period (where TEPEZZA will not be infused).
Study identification
- NCT ID
- NCT04583735
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 62 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2, 2021 (Actual)
- Primary completion
- Mar 17, 2023 (Actual)
- Completion
- Oct 12, 2023 (Actual)
- Last update posted
- Jul 1, 2024
2021 – 2023
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The Private Practice of Raymond Douglas | Beverly Hills | California | 90210 | — |
| Perlman Medical Offices / UCSD | La Jolla | California | 92037 | — |
| MACRO Trials | Los Angeles | California | 90048 | — |
| Univ of Colorado Dept of Ophthalmology | Aurora | Colorado | 80045 | — |
| Bascom Palmer Eye Institute / Univ of Miami | Miami | Florida | 33136 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Washington University | St Louis | Missouri | 63108 | — |
| Las Vegas Endocrinology | Las Vegas | Nevada | 89074 | — |
| Endocrinology Specialists & Thyroid Center | Greenville | South Carolina | 29605 | — |
| Hamilton Eye Institute / U Tennessee | Memphis | Tennessee | 38163 | — |
| Neuro-Eye Clinical Trials | Houston | Texas | 77401 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 52336 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04583735, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 1, 2024 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04583735 live on ClinicalTrials.gov.